Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Medtronic in Asia: Japanese Resolute Integrity sales and the 1st R&D lab in China
Medical device giant Medtronic launches its Resolute Integrity drug-eluting coronary stents on the Japanese market and opens its 1st research & development facility in China.
2. TAVI at ESC 2012: Germans quickly adopt minimally invasive valve replacement
About half of all elderly patients in Germany receive transcatheter aortic valve replacement therapy, but adverse event rates remain low.
1. Mixed reactions to St. Jude’s latest Fame II stent study
More findings and analysis from St. Jude Medical’s Fame II trial, studying fractional flow reserve-directing coronary stenting, leave some with "more questions than answers."
